Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2016 Conference Call

Friday, February 17, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

MISSISSAUGA, ON, Feb. 16, 2017 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) today announced it will host a conference call

its Q4 and full-year 2016 financial results on Thursday, March 2, 2017.

Q4 AND YEAR-END 2016 CONFERENCE CALL

WHEN: Thursday, March 2, 2017 at 8:30AM ET

CONFERENCE CALL/WEBCAST: You can join the call

by dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will be available through www.cipherpharma.com or http://bit.ly/2kOtP5S. An archived replay of the webcast will be available for 90 days.

About Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals (TSX:CPH) is a growing specialty pharmaceutical dermatology company, with a robust and diversified portfolio of commercial and early to late-stage products. Through multiple transactions, Cipher has built its U.S. commercial presence, expanded its Canadian dermatology franchise and broadened its pipeline. Cipher is well-capitalized to drive long-term, sustained earnings growth by leveraging its proven clinical development capabilities and efficient commercial execution. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store